Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

To mark this year’s World Hepatitis Day (28 July 2025), the NIHR School for Primary Care Research (SPCR) is highlighting projects that raise awareness of hepatitis and related health inequalities.

SPCR IN Focus | World Hepatitis Day

To mark World Hepatitis Day (28 July 2025), the NIHR School for Primary Care Research (SPCR) is showcasing work focused on tackling health inequalities. This includes research exploring the links between blood-borne virus infections and poor air quality, as well as projects aimed at improving the detection and management of undiagnosed HIV, Hepatitis B, and Hepatitis C in primary care. Using digital technology, these initiatives support targeted testing to increase identification and enhance care pathways for higher-risk and underserved communities.

One such project, led by Dr Werner Leber and colleagues (SPCR Project 679), is focused on improving the detection and care of undiagnosed HIV, Hepatitis B, and Hepatitis C in primary care using digital risk-scoring tools. Funded by the SPCR, the study addresses the reality that significant numbers of people in the UK are infected but unaware—particularly in disadvantaged groups.

SPCR is also sharing a case study highlighting the work of Professor Chris Griffiths and Dr Werner Leber, who have led influential cluster randomised trials showing that primary care is an effective setting for infectious disease screening. Working with practices serving disadvantaged migrant communities in East London, they successfully increased detection rates of TB, HIV, and hepatitis B and C through targeted screening programmes. Read more of this case study.